ALT 0 3 0 3 B-clinical_variable
, 3 4 3 4 O
AST 5 8 5 8 B-clinical_variable
, 8 9 8 9 O
AP 10 12 10 12 B-clinical_variable
: 12 13 12 13 O
≤ 14 15 14 15 O
5 16 17 16 17 B-upper_bound
times 18 23 18 23 I-upper_bound
ULN 24 27 24 27 I-upper_bound
( 28 29 28 29 I-upper_bound
upper 29 34 29 34 I-upper_bound
limit 35 40 35 40 I-upper_bound
of 41 43 41 43 I-upper_bound
normal 44 50 44 50 I-upper_bound
) 50 51 50 51 I-upper_bound

Administration 0 14 52 66 O
of 15 17 67 69 O
any 18 21 70 73 O
other 22 27 74 79 O
investigational 28 43 80 95 B-treatment
medicinal 44 53 96 105 I-treatment
product 54 61 106 113 I-treatment
within 62 68 114 120 O
60 69 71 121 123 B-upper_bound
days 72 76 124 128 I-upper_bound
prior 77 82 129 134 I-upper_bound
to 83 85 135 137 O
entry 86 91 138 143 O

Albumin 0 7 144 151 B-clinical_variable
: 7 8 151 152 O
> 9 10 153 154 O
30 11 13 155 157 B-lower_bound
g 14 15 158 159 I-lower_bound
/ 15 16 159 160 I-lower_bound
L 16 17 160 161 I-lower_bound

Any 0 3 162 165 O
extensive 4 13 166 175 O
radiotherapy 14 26 176 188 B-treatment
≤ 27 28 189 190 O
3 29 30 191 192 B-upper_bound
months 31 37 193 199 I-upper_bound
before 38 44 200 206 I-upper_bound
enrolment 45 54 207 216 O

Any 0 3 217 220 O
previous 4 12 221 229 B-treatment
peptide 13 20 230 237 I-treatment
receptor 21 29 238 246 I-treatment
radionuclide 30 42 247 259 I-treatment
therapy 43 50 260 267 I-treatment
( 51 52 268 269 I-treatment
PRRT 52 56 269 273 I-treatment
) 56 57 273 274 I-treatment

Any 0 3 275 278 O
uncontrolled 4 16 279 291 O
significant 17 28 292 303 O
medical 29 36 304 311 O
, 36 37 311 312 O
psychiatric 38 49 313 324 B-chronic_disease
or 50 52 325 327 O
surgical 53 61 328 336 O
condition 62 71 337 346 O
( 72 73 347 348 O
active 73 79 348 354 B-chronic_disease
infection 80 89 355 364 I-chronic_disease
, 89 90 364 365 O
unstable 91 99 366 374 B-chronic_disease
angina 100 106 375 381 I-chronic_disease
pectoris 107 115 382 390 I-chronic_disease
, 115 116 390 391 O
cardiac 117 124 392 399 B-chronic_disease
arrhythmia 125 135 400 410 I-chronic_disease
, 135 136 410 411 O
poorly 137 143 412 418 O
controlled 144 154 419 429 O
hypertension 155 167 430 442 B-chronic_disease
, 167 168 442 443 O
poorly 169 175 444 450 O
controlled 176 186 451 461 O
diabetes 187 195 462 470 B-chronic_disease
mellitus 196 204 471 479 I-chronic_disease
[ 205 206 480 481 O
HbA1c 206 211 481 486 B-clinical_variable
≥9 212 214 487 489 O
% 214 215 489 490 I-lower_bound
] 215 216 490 491 O
, 216 217 491 492 O
uncontrolled 218 230 493 505 O
congestive 231 241 506 516 B-chronic_disease
heart 242 247 517 522 I-chronic_disease
disease 248 255 523 530 I-chronic_disease
, 255 256 530 531 O
etc 257 260 532 535 O
. 260 261 535 536 O
) 261 262 536 537 O
or 263 265 538 540 O
laboratory 266 276 541 551 O
findings 277 285 552 560 O
that 286 290 561 565 O
, 290 291 565 566 O
in 292 294 567 569 O
the 295 298 570 573 O
opinion 299 306 574 581 O
of 307 309 582 584 O
the 310 313 585 588 O
investigator 314 326 589 601 O
, 326 327 601 602 O
might 328 333 603 608 O
jeopardize 334 344 609 619 O
the 345 348 620 623 O
patient 349 356 624 631 O
's 356 358 631 633 O
safety 359 365 634 640 O
or 366 368 641 643 O
that 369 373 644 648 O
would 374 379 649 654 O
limit 380 385 655 660 O
compliance 386 396 661 671 O
with 397 401 672 676 O
the 402 405 677 680 O
objectives 406 416 681 691 O
and 417 420 692 695 O
assessments 421 432 696 707 O
of 433 435 708 710 O
the 436 439 711 714 O
study 440 445 715 720 O

Bilirubin 0 9 721 730 B-clinical_variable
: 9 10 730 731 O
≤ 11 12 732 733 O
2 13 14 734 735 B-upper_bound
times 15 20 736 741 I-upper_bound
ULN 21 24 742 745 I-upper_bound
( 25 26 746 747 O
2x 26 28 747 749 B-upper_bound
1.1 29 32 750 753 I-upper_bound
mg 33 35 754 756 I-upper_bound
/ 35 36 756 757 I-upper_bound
dL 36 38 757 759 I-upper_bound
) 38 39 759 760 O

Calculated 0 10 761 771 B-clinical_variable
GFR 11 14 772 775 I-clinical_variable
≥ 15 16 776 777 O
55 17 19 778 780 B-lower_bound
mL 20 22 781 783 I-lower_bound
/ 22 23 783 784 I-lower_bound
min 23 26 784 787 I-lower_bound

Chemotherapy 0 12 788 800 B-treatment
≤ 13 14 801 802 O
3 15 16 803 804 B-upper_bound
months 17 23 805 811 I-upper_bound
before 24 30 812 818 I-upper_bound
enrolment 31 40 819 828 O

Confirmed 0 9 829 838 O
presence 10 18 839 847 O
of 19 21 848 850 O
somatostatin 22 34 851 863 O
receptors 35 44 864 873 O
on 45 47 874 876 O
technically 48 59 877 888 O
evaluable 60 69 889 898 O
tumor 70 75 899 904 B-cancer
lesions 76 83 905 912 O
documented 84 94 913 923 O
by 95 97 924 926 O
a 98 99 927 928 O
positive 100 108 929 937 B-treatment
Somatostatin 109 121 938 950 I-treatment
Receptor 122 130 951 959 I-treatment
Scan 131 135 960 964 I-treatment
performed 136 145 965 974 O
within 146 152 975 981 O
6 153 154 982 983 B-upper_bound
months 155 161 984 990 I-upper_bound
prior 162 167 991 996 I-upper_bound
to 168 170 997 999 O
enrolment 171 180 1000 1009 O
in 181 183 1010 1012 O
the 184 187 1013 1016 O
study 188 193 1017 1022 O

Current 0 7 1023 1030 O
history 8 15 1031 1038 O
of 16 18 1039 1041 O
any 19 22 1042 1045 O
malignancy 23 33 1046 1056 B-cancer
other 34 39 1057 1062 O
than 40 44 1063 1067 O
NET 45 48 1068 1071 B-cancer
within 49 55 1072 1078 O
5 56 57 1079 1080 B-upper_bound
years 58 63 1081 1086 I-upper_bound
of 64 66 1087 1089 O
enrolment 67 76 1090 1099 O
except 77 83 1100 1106 O
for 84 87 1107 1110 O
fully 88 93 1111 1116 O
-resected 94 103 1117 1126 O
non 104 107 1127 1130 B-cancer
- 107 108 1130 1131 I-cancer
melanoma 108 116 1131 1139 I-cancer
skin 117 121 1140 1144 I-cancer
cancer 122 128 1145 1151 I-cancer
or 129 131 1152 1154 O
cervical 132 140 1155 1163 B-cancer
cancer 141 147 1164 1170 I-cancer
in 148 150 1171 1173 I-cancer
situ 151 155 1174 1178 I-cancer

Current 0 7 1179 1186 O
history 8 15 1187 1194 O
of 16 18 1195 1197 O
malignancy 19 29 1198 1208 B-cancer
; 29 30 1208 1209 O
patients 31 39 1210 1218 O
with 40 44 1219 1223 O
a 45 46 1224 1225 O
secondary 47 56 1226 1235 B-clinical_variable
tumor 57 62 1236 1241 I-clinical_variable
in 63 65 1242 1244 O
remission 66 75 1245 1254 O
of 76 78 1255 1257 O
> 79 80 1258 1259 O
5 81 82 1260 1261 B-lower_bound
years 83 88 1262 1267 I-lower_bound
can 89 92 1268 1271 O
be 93 95 1272 1274 O
included 96 104 1275 1283 O

Diagnosis 0 9 1284 1293 O
of 10 12 1294 1296 O
thymic 13 19 1297 1303 B-chronic_disease
NET 20 23 1304 1307 I-chronic_disease

Documentation 0 13 1308 1321 O
of 14 16 1322 1324 O
progressive 17 28 1325 1336 O
disease 29 36 1337 1344 O
based 37 42 1345 1350 O
on 43 45 1351 1353 O
RECIST 46 52 1354 1360 O
v1.1 53 57 1361 1365 O
under 58 63 1366 1371 O
prior 64 69 1372 1377 B-treatment
anti 70 74 1378 1382 I-treatment
- 74 75 1382 1383 I-treatment
tumor 75 80 1383 1388 I-treatment
therapy 81 88 1389 1396 I-treatment
within 89 95 1397 1403 O
6 96 97 1404 1405 O
months 98 104 1406 1412 O
of 105 107 1413 1415 O
entry 108 113 1416 1421 O
in 114 116 1422 1424 O
the 117 120 1425 1428 O
study 121 126 1429 1434 O
( 127 128 1435 1436 O
although 128 136 1436 1444 O
the 137 140 1445 1448 O
progression 141 152 1449 1460 O
might 153 158 1461 1466 O
have 159 163 1467 1471 O
occurred 164 172 1472 1480 O
more 173 177 1481 1485 O
than 178 182 1486 1490 O
6 183 184 1491 1492 O
months 185 191 1493 1499 O
before 192 198 1500 1506 O
study 199 204 1507 1512 O
entry 205 210 1513 1518 O
) 210 211 1518 1519 O

Erythrocytes 0 12 1520 1532 B-clinical_variable
: 12 13 1532 1533 O
≥ 14 15 1534 1535 O
3.5 16 19 1536 1539 B-lower_bound
* 19 20 1539 1540 I-lower_bound
12 20 22 1540 1542 I-lower_bound
^ 22 23 1542 1543 I-lower_bound
9 23 24 1543 1544 I-lower_bound
/ 24 25 1544 1545 I-lower_bound
L 25 26 1545 1546 I-lower_bound

In 0 2 1547 1549 O
countries 3 12 1550 1559 O
where 13 18 1560 1565 O
sunitinib 19 28 1566 1575 B-treatment
or 29 31 1576 1578 O
everolimus 32 42 1579 1589 B-treatment
are 43 46 1590 1593 O
marketed 47 55 1594 1602 O
, 55 56 1602 1603 O
patients 57 65 1604 1612 O
with 66 70 1613 1617 O
GEP 71 74 1618 1621 B-cancer
NET 75 78 1622 1625 I-cancer
and 79 82 1626 1629 O
lung 83 87 1630 1634 B-cancer
NET 88 91 1635 1638 I-cancer
will 92 96 1639 1643 O
be 97 99 1644 1646 O
progressive 100 111 1647 1658 O
under 112 117 1659 1664 O
this 118 122 1665 1669 O
prior 123 128 1670 1675 B-treatment
anti 129 133 1676 1680 I-treatment
- 133 134 1680 1681 I-treatment
tumor 134 139 1681 1686 I-treatment
treatment 140 149 1687 1696 I-treatment
for 150 153 1697 1700 O
the 154 157 1701 1704 O
respective 158 168 1705 1715 O
indication 169 179 1716 1726 O

Karnofsky 0 9 1727 1736 B-clinical_variable
performance 10 21 1737 1748 I-clinical_variable
score 22 27 1749 1754 I-clinical_variable
≥ 28 29 1755 1756 O
60 30 32 1757 1759 B-lower_bound

Known 0 5 1760 1765 O
hypersensitivity 6 22 1766 1782 O
to 23 25 1783 1785 O
177Lu 26 31 1786 1791 B-allergy_name
, 31 32 1791 1792 O
to 33 35 1793 1795 O
DOTA 36 40 1796 1800 B-allergy_name
, 40 41 1800 1801 O
to 42 44 1802 1804 O
JR11 45 49 1805 1809 B-allergy_name
or 50 52 1810 1812 O
to 53 55 1813 1815 O
any 56 59 1816 1819 O
of 60 62 1820 1822 O
the 63 66 1823 1826 O
excipients 67 77 1827 1837 B-allergy_name
of 78 80 1838 1840 I-allergy_name
177Lu 81 86 1841 1846 I-allergy_name
- 86 87 1846 1847 I-allergy_name
OPS201 87 93 1847 1853 I-allergy_name

Leukocytes 0 10 1854 1864 B-clinical_variable
: 10 11 1864 1865 O
≥ 12 13 1866 1867 O
4 14 15 1868 1869 B-lower_bound
* 15 16 1869 1870 I-lower_bound
10 16 18 1870 1872 I-lower_bound
^ 18 19 1872 1873 I-lower_bound
9 19 20 1873 1874 I-lower_bound
/ 20 21 1874 1875 I-lower_bound
L 21 22 1875 1876 I-lower_bound

Life 0 4 1877 1881 B-clinical_variable
expectancy 5 15 1882 1892 I-clinical_variable
of 16 18 1893 1895 O
at 19 21 1896 1898 O
least 22 27 1899 1904 O
6 28 29 1905 1906 B-lower_bound
months 30 36 1907 1913 I-lower_bound

Male 0 4 1914 1918 B-gender
patients 5 13 1919 1927 I-gender
must 14 18 1928 1932 O
use 19 22 1933 1936 B-contraception_consent
a 23 24 1937 1938 I-contraception_consent
medically 25 34 1939 1948 I-contraception_consent
accepted 35 43 1949 1957 I-contraception_consent
method 44 50 1958 1964 I-contraception_consent
of 51 53 1965 1967 I-contraception_consent
contraception 54 67 1968 1981 I-contraception_consent
and 68 71 1982 1985 O
must 72 76 1986 1990 O
agree 77 82 1991 1996 B-contraception_consent
to 83 85 1997 1999 I-contraception_consent
continue 86 94 2000 2008 I-contraception_consent
use 95 98 2009 2012 I-contraception_consent
of 99 101 2013 2015 I-contraception_consent
this 102 106 2016 2020 I-contraception_consent
method 107 113 2021 2027 I-contraception_consent
for 114 117 2028 2031 O
the 118 121 2032 2035 O
duration 122 130 2036 2044 O
of 131 133 2045 2047 O
the 134 137 2048 2051 O
study 138 143 2052 2057 O
and 144 147 2058 2061 O
for 148 151 2062 2065 O
6 152 153 2066 2067 B-upper_bound
months 154 160 2068 2074 I-upper_bound
after 161 166 2075 2080 O
the 167 170 2081 2084 O
last 171 175 2085 2089 O
activity 176 184 2090 2098 O
administration 185 199 2099 2113 O

Measurable 0 10 2114 2124 B-chronic_disease
disease 11 18 2125 2132 I-chronic_disease
based 19 24 2133 2138 O
on 25 27 2139 2141 O
RECIST 28 34 2142 2148 O
v1.1 35 39 2149 2153 O

Nephrectomy 0 11 2154 2165 B-treatment
, 11 12 2165 2166 O
renal 13 18 2167 2172 B-treatment
transplant 19 29 2173 2183 I-treatment
or 30 32 2184 2186 O
concomitant 33 44 2187 2198 O
nephrotoxic 45 56 2199 2210 B-treatment
therapy 57 64 2211 2218 I-treatment
putting 65 72 2219 2226 O
the 73 76 2227 2230 O
subject 77 84 2231 2238 O
at 85 87 2239 2241 O
high 88 92 2242 2246 O
risk 93 97 2247 2251 O
of 98 100 2252 2254 O
renal 101 106 2255 2260 B-chronic_disease
toxicity 107 115 2261 2269 I-chronic_disease
during 116 122 2270 2276 O
the 123 126 2277 2280 O
study 127 132 2281 2286 O
as 133 135 2287 2289 O
assessed 136 144 2290 2298 O
by 145 147 2299 2301 O
the 148 151 2302 2305 O
investigator 152 164 2306 2318 O

Platelets 0 9 2319 2328 B-clinical_variable
: 9 10 2328 2329 O
≥ 11 12 2330 2331 O
100 13 16 2332 2335 B-lower_bound
* 16 17 2335 2336 I-lower_bound
10 17 19 2336 2338 I-lower_bound
^ 19 20 2338 2339 I-lower_bound
9 20 21 2339 2340 I-lower_bound
/ 21 22 2340 2341 I-lower_bound
L 22 23 2341 2342 I-lower_bound

Pregnant 0 8 2343 2351 B-pregnancy
or 9 11 2352 2354 O
breast 12 18 2355 2361 O
- 18 19 2361 2362 O
feeding 19 26 2362 2369 O
women 27 32 2370 2375 B-gender

Presence 0 8 2376 2384 O
of 9 11 2385 2387 O
active 12 18 2388 2394 B-chronic_disease
infection 19 28 2395 2404 I-chronic_disease
at 29 31 2405 2407 O
screening 32 41 2408 2417 O
or 42 44 2418 2420 O
history 45 52 2421 2428 O
of 53 55 2429 2431 O
serious 56 63 2432 2439 O
infection 64 73 2440 2449 O
within 74 80 2450 2456 O
the 81 84 2457 2460 O
previous 85 93 2461 2469 B-upper_bound
6 94 95 2470 2471 I-upper_bound
weeks 96 101 2472 2477 I-upper_bound

Prior 0 5 2478 2483 O
or 6 8 2484 2486 O
planned 9 16 2487 2494 O
administration 17 31 2495 2509 O
of 32 34 2510 2512 O
a 35 36 2513 2514 O
therapeutic 37 48 2515 2526 B-treatment
radiopharmaceutical 49 68 2527 2546 I-treatment
within 69 75 2547 2553 O
8 76 77 2554 2555 B-upper_bound
half 78 82 2556 2560 I-upper_bound
- 82 83 2560 2561 I-upper_bound
lives 83 88 2561 2566 I-upper_bound
of 89 91 2567 2569 O
the 92 95 2570 2573 O
radionuclide 96 108 2574 2586 B-treatment
including 109 118 2587 2596 O
any 119 122 2597 2600 O
time 123 127 2601 2605 O
during 128 134 2606 2612 O
the 135 138 2613 2616 O
current 139 146 2617 2624 O
study 147 152 2625 2630 O

Women 0 5 2631 2636 B-gender
of 6 8 2637 2639 O
childbearing 9 21 2640 2652 O
potential 22 31 2653 2662 O
( 32 33 2663 2664 O
not 33 36 2664 2667 O
surgically 37 47 2668 2678 B-treatment
sterile 48 55 2679 2686 I-treatment
or 56 58 2687 2689 O
less 59 63 2690 2694 O
than 64 68 2695 2699 O
2 69 70 2700 2701 B-upper_bound
years 71 76 2702 2707 I-upper_bound
postmenopausal 77 91 2708 2722 O
) 91 92 2722 2723 O
must 93 97 2724 2728 O
use 98 101 2729 2732 B-contraception_consent
a 102 103 2733 2734 I-contraception_consent
medically 104 113 2735 2744 I-contraception_consent
accepted 114 122 2745 2753 I-contraception_consent
method 123 129 2754 2760 I-contraception_consent
of 130 132 2761 2763 I-contraception_consent
contraception 133 146 2764 2777 I-contraception_consent
and 147 150 2778 2781 O
must 151 155 2782 2786 O
agree 156 161 2787 2792 B-contraception_consent
to 162 164 2793 2795 I-contraception_consent
continue 165 173 2796 2804 I-contraception_consent
use 174 177 2805 2808 I-contraception_consent
of 178 180 2809 2811 I-contraception_consent
this 181 185 2812 2816 I-contraception_consent
method 186 192 2817 2823 I-contraception_consent
for 193 196 2824 2827 O
the 197 200 2828 2831 O
duration 201 209 2832 2840 O
of 210 212 2841 2843 O
the 213 216 2844 2847 O
study 217 222 2848 2853 O
and 223 226 2854 2857 O
for 227 230 2858 2861 O
6 231 232 2862 2863 B-upper_bound
months 233 239 2864 2870 I-upper_bound
after 240 245 2871 2876 I-upper_bound
the 246 249 2877 2880 O
last 250 254 2881 2885 O
dose 255 259 2886 2890 O

aged 0 4 2891 2895 B-age
≥ 5 6 2896 2897 O
18 7 9 2898 2900 B-lower_bound
years 10 15 2901 2906 I-lower_bound

malignant 0 9 2907 2916 B-cancer
, 9 10 2916 2917 O
unresectable 11 23 2918 2930 O
pheochromocytoma 24 40 2931 2947 B-cancer
or 41 43 2948 2950 O
paraganglioma 44 57 2951 2964 B-cancer

unresectable 0 12 2965 2977 O
GEP 13 16 2978 2981 B-cancer
NET 17 20 2982 2985 I-cancer
( 21 22 2986 2987 O
Grade 22 27 2987 2992 O
I 28 29 2993 2994 O
and 30 33 2995 2998 O
Grade 34 39 2999 3004 O
II 40 42 3005 3007 O
according 43 52 3008 3017 O
to 53 55 3018 3020 O
WHO 56 59 3021 3024 O
classification 60 74 3025 3039 O
( 75 76 3040 3041 O
2010 76 80 3041 3045 O
, 80 81 3045 3046 O
Annex 82 87 3047 3052 O
01 88 90 3053 3055 O
) 90 91 3055 3056 O
, 91 92 3056 3057 O
functioning 93 104 3058 3069 O
and 105 108 3070 3073 O
non 109 112 3074 3077 O
- 112 113 3077 3078 O
functioning 113 124 3078 3089 O
) 124 125 3089 3090 O

unresectable 0 12 3091 3103 O
typical 13 20 3104 3111 O
lung 21 25 3112 3116 B-cancer
carcinoid 26 35 3117 3126 I-cancer
or 36 38 3127 3129 O
atypical 39 47 3130 3138 O
lung 48 52 3139 3143 O
carcinoid 53 62 3144 3153 O
are 63 66 3154 3157 O
acceptable 67 77 3158 3168 O
( 78 79 3169 3170 O
with 79 83 3170 3174 O
the 84 87 3175 3178 O
exception 88 97 3179 3188 O
of 98 100 3189 3191 O
Large 101 106 3192 3197 B-cancer
Cell 107 111 3198 3202 I-cancer
Bronchial 112 121 3203 3212 I-cancer
Neuroendocrine 122 136 3213 3227 I-cancer
Neoplasms 137 146 3228 3237 I-cancer
and 147 150 3238 3241 O
Small 151 156 3242 3247 B-cancer
Cell 157 161 3248 3252 I-cancer
Lung 162 166 3253 3257 I-cancer
Cancers 167 174 3258 3265 I-cancer
) 174 175 3265 3266 O
( 176 177 3267 3268 O
Caplin 177 183 3268 3274 O
2015 184 188 3275 3279 O
) 188 189 3279 3280 O

